Extracellular Vesicle‐Mediated Regulation of H3C14 Contributes to Gemcitabine Resistance in Bladder Cancer
Journal of Extracellular Vesicles · 2025
DOI: 10.1002/jev2.70179 ↗At a glance
Journal article in Journal of Extracellular Vesicles, 2025. Written by Cheng-Shuo Huang and 5 co-authors. Institution: Graduate Institute of Life Sciences, College of Biomedical Sciences, National Defense Medical University, Taipei, Taiwan. Major MEDLINE topics: Urinary Bladder Neoplasms, Extracellular Vesicles, Deoxycytidine, Drug Resistance, Neoplasm. Cited 9 times so far (Crossref); 106 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Science and Technology Council Overseas Project for Post Graduate Research, National Science and Technology Council, National Defense Medical Center.
Abstract (original language)
Extracellular vesicles (EVs) are critical mediators of intercellular communication within the tumour microenvironment and play a significant role in drug resistance. We aimed to investigate the mechanisms underlying gemcitabine (GCB) resistance in bladder cancer. GCB‐resistant bladder cancer cells exhibited dysregulation of nucleoside‐metabolizing enzymes and transporters. Characterization of EV subpopulations derived from GCB‐resistant cells revealed their ability to transfer drug‐resistant phenotypes to naïve cancer cells by modulating intracellular levels of nucleoside metabolic proteins and transporters. Proteomic and transcriptomic analyses identified the histone protein H3.2 and its corresponding transcript, H3C14, as key regulators in the transmission of GCB resistance. Notably, H3C14 overexpression in resistant cells restored GCB sensitivity, whereas its knockdown induced GCB resistance. Rab27A‐mediated biogenesis and secretion emerged as a crucial mechanism regulating EV release and H3C14 excretion in GCB‐resistant cells. A specific EV subpopulation enriched in CD147 and LAMB1—referred to as Excretion EVs—carried H3.2 (H3C14) but did not induce GCB resistance in recipient cells, suggesting their primary role in eliminating proteins associated with tumour progression and drug resistance. These findings highlight the role of EV‐mediated H3C14 excretion in regulating GCB resistance and suggest potential therapeutic strategies targeting EV pathways to overcome drug resistance in bladder cancer.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Graduate Institute of Life Sciences, College of Biomedical Sciences, National Defense Medical University, Taipei, Taiwan.
- Graduate Institute of Pathology and Parasitology, College of Medicine, National Defense Medical University, Taipei, Taiwan.
- Department of Pathology, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.
- National Institute of Cancer Research, National Health Research Institutes, Miaoli, Taiwan.
- Department of Integrative Biology and Pharmacology, McGovern Medical School, the University of Texas Health Science Center at Houston, Houston, Texas, USA.
- Division of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.
ORCID profiles: Cheng-Shuo Huang
Funding
- National Science and Technology Council Overseas Project for Post Graduate Research
- National Science and Technology Council
- National Defense Medical Center
- Tri-Service General Hospital
Cite
APA
Huang, C. S., Yu, D. S., Jiang, S. S., Wu, Y. S., Ho, J. Y., & Yu, C. P. (2025). Extracellular Vesicle‐Mediated Regulation of H3C14 Contributes to Gemcitabine Resistance in Bladder Cancer. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.70179
Vancouver
Huang CS, Yu DS, Jiang SS, Wu YS, Ho JY, Yu CP. Extracellular Vesicle‐Mediated Regulation of H3C14 Contributes to Gemcitabine Resistance in Bladder Cancer. Journal of Extracellular Vesicles. 2025. doi:10.1002/jev2.70179
BibTeX
@article{Huang2025,
author = {Huang, Cheng-Shuo and Yu, Dah-Shyong and Jiang, Shih Sheng and Wu, Ying-Si and Ho, Jar-Yi and Yu, Cheng-Ping},
title = {Extracellular Vesicle‐Mediated Regulation of H3C14 Contributes to Gemcitabine Resistance in Bladder Cancer},
journal = {Journal of Extracellular Vesicles},
year = {2025},
doi = {10.1002/jev2.70179}
}
EUVIMED